Fenofibrate communicates with PPARα, activates PPARα related signaling pathways mediate adipocyte proliferation, regulates body fat metabolism, facilitates fat redistribution, avoids excessive accumulation of liver fat, and improves non-alcoholic fatty liver disease. The gene discussed is PPARA; the disease is metabolic dysfunction-associated steatotic liver disease.